126 related articles for article (PubMed ID: 20382529)
1. Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers.
Gu SJ; Lee JK; Pae AN; Chung HJ; Rhim H; Han SY; Min SJ; Cho YS
Bioorg Med Chem Lett; 2010 May; 20(9):2705-8. PubMed ID: 20382529
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers.
Park JE; Ji WK; Jang JW; Pae AN; Choi K; Choi KH; Kang J; Roh EJ
Bioorg Med Chem Lett; 2013 Mar; 23(6):1887-90. PubMed ID: 23395659
[TBL] [Abstract][Full Text] [Related]
3. Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers.
Choi YH; Baek du J; Seo SH; Lee JK; Pae AN; Cho YS; Min SJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):215-9. PubMed ID: 21126876
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels.
Sairaman A; Cardoso FC; Bispat A; Lewis RJ; Duggan PJ; Tuck KL
Bioorg Med Chem; 2018 Jul; 26(11):3046-3059. PubMed ID: 29622412
[TBL] [Abstract][Full Text] [Related]
5. Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.
Choi YJ; Seo JH; Shin KJ
Bioorg Med Chem Lett; 2014 Feb; 24(3):880-3. PubMed ID: 24412109
[TBL] [Abstract][Full Text] [Related]
6. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
Rhim H; Lee YS; Park SJ; Chung BY; Lee JY
Bioorg Med Chem Lett; 2005 Jan; 15(2):283-6. PubMed ID: 15603940
[TBL] [Abstract][Full Text] [Related]
8. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
[TBL] [Abstract][Full Text] [Related]
10. Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor.
Giordanetto F; Wållberg A; Knerr L; Selmi N; Ullah V; Thorstensson F; Lindelöf Å; Karlsson S; Nikitidis G; Llinas A; Wang QD; Lindqvist A; Högberg G; Lindhardt E; Åstrand A; Duker G
Bioorg Med Chem Lett; 2013 Jan; 23(1):119-24. PubMed ID: 23200256
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR study of T-type calcium channel blockers. Part II.
Choe YJ; Seo HN; Jung SY; Rhim H; Kim J; Choo DJ; Lee JY
Arch Pharm (Weinheim); 2008 Oct; 341(10):661-4. PubMed ID: 18816587
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacological evaluation of 1-alkyl-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.
Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
Chem Pharm Bull (Tokyo); 2011; 59(11):1376-85. PubMed ID: 22041074
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
Jung HK; Doddareddy MR; Cha JH; Rhim H; Cho YS; Koh HY; Jung BY; Pae AN
Bioorg Med Chem; 2004 Aug; 12(15):3965-70. PubMed ID: 15246072
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
Lee JE; Koh HY; Seo SH; Baek YY; Rhim H; Cho YS; Choo H; Pae AN
Bioorg Med Chem Lett; 2010 Jul; 20(14):4219-22. PubMed ID: 20621730
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and T-type calcium channel-blocking effects of aryl(1,5-disubstituted-pyrazol-3-yl)methyl sulfonamides for neuropathic pain treatment.
Kim JH; Keum G; Chung H; Nam G
Eur J Med Chem; 2016 Nov; 123():665-672. PubMed ID: 27517811
[TBL] [Abstract][Full Text] [Related]
17. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
Lee HK; Lee YS; Roh EJ; Rhim H; Lee JY; Shin KJ
Bioorg Med Chem Lett; 2008 Aug; 18(15):4424-7. PubMed ID: 18625556
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 6-pyrazoylamido-3N-substituted azabicyclo[3,1,0]hexane derivatives as T-type calcium channel inhibitors for treatment of neuropathic pain.
Kim JH; Nam G
Bioorg Med Chem; 2016 Nov; 24(21):5028-5035. PubMed ID: 27591007
[TBL] [Abstract][Full Text] [Related]
20. T-type Ca2+ channel blockers suppress the growth of human cancer cells.
Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY
Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
